These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 549256)

  • 21. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS; Forman R; Klein NA; Sonnenblick EH; LeJemtel TH
    Am J Med; 1982 Jan; 72(1):113-8. PubMed ID: 7058816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of amrinone, a new non-digitalic positive inotropic agent, on the efficiency and coronary circulation of the heart].
    Bárcenas L; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(5):431-40. PubMed ID: 6517640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic changes caused by a single intravenous dose of amrinone in congestive heart failure].
    Zhi G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):218-20. PubMed ID: 2560706
    [No Abstract]   [Full Text] [Related]  

  • 24. [The hemodynamic profile of the response to amrinone treatment in severe heart failure].
    Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A
    Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and hemodynamics of amrinone in patients with chronic cardiac failure of diverse etiology.
    Wilson H; Rocci ML; Weber KT; Andrews V; Likoff MJ
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):3-19. PubMed ID: 3589153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amrinone in catecholamine refractory heart failure in septic shock].
    Hoffmann P; Schockenhoff B
    Anaesthesist; 1985 Dec; 34(12):663-9. PubMed ID: 4096358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravenous molsidomine administration in heart failure. Part I: Dose-response relationship with reference to hemodynamic parameters].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():47-9. PubMed ID: 7968903
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodynamic effects of amrinone on patients with moderate and severe cardiac dysfunction after open heart surgery].
    Kunimoto F; Arai K; Isa Y; Satoh Y; Fujita T; Koyano T; Nagasawa S; Ohbayashi T; Kaneko T
    Masui; 1995 Jan; 44(1):42-50. PubMed ID: 7699823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH; Kapur PA
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amrinone-induced thrombocytopenia.
    Ansell J; Tiarks C; McCue J; Parrilla N; Benotti JR
    Arch Intern Med; 1984 May; 144(5):949-52. PubMed ID: 6712412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the action of Cordemcura on selected cardiovascular parameters following intraduodenal and intravenous application in beagles].
    Hübler D; Mudhaffar AA; Schilling G; Elze M; Chemnitius KH
    Pharmazie; 1986 Mar; 41(3):196-9. PubMed ID: 3714795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral amrinone in refractory congestive heart failure.
    Wynne J; Malacoff RF; Benotti JR; Curfman GD; Grossman W; Holman BL; Smith TW; Braunwald E
    Am J Cardiol; 1980 Jun; 45(6):1245-9. PubMed ID: 7377123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute pharmacodynamics and pharmacokinetics of oral amrinone.
    Benotti JR; Lesko LJ; McCue JE
    J Clin Pharmacol; 1982 Oct; 22(10):425-32. PubMed ID: 7174852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side effects of amrinone therapy.
    Wilsmhurst PT; Webb-Peploe MM
    Br Heart J; 1983 May; 49(5):447-51. PubMed ID: 6838732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience with amrinone in patients with advanced congestive heart failure.
    Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
    J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical studies with beta 2 adrenoceptor agonists in heart failure.
    Dawson JR; Bayliss J; Norell MS; Canepa-Anson R; Kuan P; Reuben S; Poole-Wilson PA; Sutton GC
    Eur Heart J; 1982 Dec; 3 Suppl D():135-41. PubMed ID: 6130947
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
    Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
    Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute hemodynamic effects of intravenous administration of molsidomine in secondary pulmonary hypertension and right heart failure].
    Jahed MM
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():58-61. PubMed ID: 7968906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.